NASH can occur in patients with MAFLD, irrespective of alanine transaminase (ALT) levels, and ultrasound grading of the severity of steatosis cannot accurately predict NASH. This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.